Page 11 - Casi Long News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Casi long. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Casi Long Today - Breaking & Trending Today

CASI Pharmaceuticals (NASDAQ:CASI) Shares Pass Above 200-Day Moving Average of $2.41

CASI Pharmaceuticals, Inc. (NASDAQ:CASI – Get Free Report) shares crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $2.41 and traded as high as $2.55. CASI Pharmaceuticals shares last traded at $2.49, with a volume of 7,682 shares traded. Wall Street Analysts Forecast Growth A […] ....

United States , New Zealand General , New Zealand , Pharmaceuticals Inc , Susquehanna International Group , Pharmaceuticals Company Profile , Casi Pharmaceuticals Inc , Wellington Shields Co , Pharmaceuticals Daily , Citigroup Inc , Pharmaceuticals Trading Down , Renaissance Technologies , Virtu Financial , Get Free Report , Trading Down , International Group , Wellington Shields , Casi Pharmaceuticals , Nasdaq Casi ,

CASI Pharmaceuticals (NASDAQ:CASI) Earns Hold Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a research note released on Thursday. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright restated a buy rating and set a $10.00 price target on shares of CASI Pharmaceuticals in a report on Monday, August 14th. […] ....

New Zealand General , New Zealand , United States , Pharmaceuticals Inc , Pharmaceuticals Daily , Citigroup Inc , Pharmaceuticals Stock Down , Wellington Shields Capital Management , Wellington Shields Co , Virtu Financial , Susquehanna International Group , Free Report , Stock Down , Get Free Report , Shields Capital Management , International Group , Casi Pharmaceuticals , Nasdaq Casi , Initiated Coverage , Stocknews Com ,

CASI Pharmaceuticals' (CASI) "Buy" Rating Reiterated at HC Wainwright

CASI Pharmaceuticals (NASDAQ:CASI – Get Free Report)‘s stock had its “buy” rating reissued by investment analysts at HC Wainwright in a note issued to investors on Monday, Benzinga reports. They currently have a $10.00 price objective on the biotechnology company’s stock. HC Wainwright’s price objective suggests a potential upside of 340.53% from the company’s current […] ....

New Zealand General , New Zealand , United States , Susquehanna International Group , Pharmaceuticals Daily , Pharmaceuticals Company Profile , Wellington Shields Capital Management , Virtu Financial , Pharmaceuticals Price Performance , Wellington Shields Co , Casi Pharmaceuticals , Pharmaceuticals Inc , Citigroup Inc , Get Free Report , Shields Capital Management , International Group , Nasdaq Casi , Reiterated Rating , Hc Wainwright ,